The global oncology clinical trials market size was estimated at USD 12.92 billion in 2022 and is projected to reach USD 19.49 billion by 2030, growing at a CAGR of 5.2% from 2023 to 2030. The market is primarily driven by factors such as an increase in technological advancements, a rise in cancer incidences, and improvements in personalized medicine and cell and gene therapies, which are starting new approaches for developing new treatments for cancer-like diseases.
